Basit öğe kaydını göster

dc.contributor.authorOztan, Ozgur
dc.contributor.authorTurksoy, Vugar A.
dc.contributor.authorDeniz, Serdar
dc.contributor.authorIritas, Servet B.
dc.contributor.authorTutkun, Engin
dc.date.accessioned2024-03-12T19:35:00Z
dc.date.available2024-03-12T19:35:00Z
dc.date.issued2022
dc.identifier.issn1433-6510
dc.identifier.urihttps://doi.org/10.7754/Clin.Lab.2021.210504
dc.identifier.urihttps://hdl.handle.net/20.500.12450/2791
dc.description.abstractBackground: In this study, we aimed to show that methylated arginines are the predictors of non-clinical atherosclerotic cardiovascular complications in metal workers exposed to Cd. Methods: The 80 Cd-exposed metal workers and 80 non-exposed workers (control) included in the study were available for measuring arginine, ADMA, SDMA, and L-NMMA levels. Results: The average urine Cd levels (CdU) found were 1.03 +/- 0.8 mu g/g creatinine (0.84 +/- 0.65 mu g/L) ranging from 0.01 to 3.00 mu g/g creatinine in the control group and 5.41 +/- 5.2 mu g/g creatinine (4.29 +/- 3.81 mu g/L) ranged from 0.11 to 27.2 mu g/g creatinine in metal workers. On the other hand, the median ratios of the different groups (exposed and control) were found to be 449.35 and 483.88 for arginine/ADMA and 1.28 and 1.33 SDMA/ADMA, respectively. Conclusions: The present study was undertaken to investigate the relationship between cadmium exposure and methylated arginines such as ADMA/SDMA/L-NMMA parameters which is important for the early detection atherosclerotic cardiovascular diseases . (Clin. Lab. 2022;68:xx-xx. DOI: 10.7754/Clin.Lab.2021.210504)en_US
dc.description.sponsorshipYozgat Bozok Univer-sity Scientific Research Foundation [6602b-TF/18-228]en_US
dc.description.sponsorshipAcknowledgment: This study was supported by the Yozgat Bozok Univer-sity Scientific Research Foundation (grant No. 6602b-TF/18-228) .en_US
dc.language.isoengen_US
dc.publisherClin Lab Publen_US
dc.relation.ispartofClinical Laboratoryen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCd exposureen_US
dc.subjectCdUen_US
dc.subjectmethylated argininesen_US
dc.subjectatherosclerotic cardiovascular diseasesen_US
dc.titleThe Relationship of Methylated Arginines with Urine Cadmium Levelsen_US
dc.typearticleen_US
dc.departmentAmasya Üniversitesien_US
dc.authoridDeniz, Serdar/0000-0002-6941-4813
dc.authoridİritaş, Servet Birgin/0000-0001-5283-9973;
dc.identifier.volume68en_US
dc.identifier.issue1en_US
dc.identifier.startpage70en_US
dc.identifier.endpage77en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopus2-s2.0-85123312249en_US
dc.identifier.doi10.7754/Clin.Lab.2021.210504
dc.department-temp[Oztan, Ozgur] HLC Med Ctr, Dept Med Management, Ankara, Turkey; [Turksoy, Vugar A.; Tutkun, Engin] Yozgat Bozok Univ, Fac Med, Dept Publ Hlth, Yozgat, Turkey; [Deniz, Serdar] Malatya Turgut Ozal Univ, Fac Med, Dept Publ Hlth, Malatya, Turkey; [Iritas, Servet B.] Amasya Univ, Dept Forens Med, Amasya, Turkeyen_US
dc.identifier.wosWOS:000719929300001en_US
dc.identifier.pmid35023667en_US
dc.authorwosidDeniz, Serdar/AAA-6094-2019
dc.authorwosidİritaş, Servet Birgin/E-6472-2016
dc.authorwosidTURKSOY, Vugar Ali/AAM-6647-2021


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster